Viking Therapeutics Ownership | Who Owns Viking Therapeutics?
Viking Therapeutics Ownership Summary
Viking Therapeutics is owned by 66.02% institutional investors, 3.09% insiders, and 30.88% retail investors. Vanguard group is the largest institutional shareholder, holding 8.89% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.
VKTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Viking Therapeutics | 66.02% | 3.09% | 30.88% |
| Sector | Healthcare Stocks | 244.37% | 12.11% | -156.48% |
| Industry | Biotech Stocks | 379.01% | 11.75% | -290.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 9.98M | 8.89% | $351.25M |
| Blackrock | 6.03M | 5.82% | $319.45M |
| Fmr | 6.34M | 5.48% | $247.16M |
| Blackrock funding, inc. /de | 6.19M | 5.36% | $241.46M |
| State street | 5.61M | 4.85% | $218.71M |
| Vanguard capital management | 5.05M | 4.37% | $197.14M |
| Two sigma investments, lp | 3.94M | 3.41% | $153.60M |
| Morgan stanley | 3.49M | 3.02% | $135.99M |
| Ameriprise financial | 2.16M | 1.87% | $84.11M |
| Geode capital management | 2.10M | 1.82% | $81.87M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Act capital management | 209.30K | 5.33% | $8.16M |
| First washington | 381.30K | 3.62% | $14.87M |
| Profit investment management | 18.00K | 2.56% | $633.07K |
| Diadema partners lp | 441.81K | 2.18% | $17.23M |
| Blackbarn capital partners lp | 600.00K | 1.97% | $23.41M |
| Toms capital investment management lp | 763.60K | 1.52% | $40.48M |
| Persistent asset partners | 112.74K | 1.31% | $4.40M |
| Artia global partners lp | 180.73K | 1.30% | $7.05M |
| Eversept partners, lp | 602.92K | 1.22% | $23.52M |
| Exome asset management | 47.86K | 1.15% | $1.87M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 1.28M | 0.01% | 1.28M |
| State street | 5.61M | 0.01% | 1.21M |
| Toms capital investment management lp | 763.60K | 1.52% | 763.60K |
| Sixth street partners management company | 730.69K | 0.00% | 730.69K |
| Jump financial | 579.88K | 0.18% | 579.88K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -3.59M |
| Blackrock | 6.03M | 0.01% | -2.25M |
| Massachusetts financial services co /ma/ | - | - | -1.36M |
| Raymond james financial | 794.66K | 0.01% | -1.28M |
| Perpetual | - | - | -1.27M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.28M | 0.01% | 1.28M | $51.46M |
| Toms capital investment management lp | 763.60K | 1.52% | 763.60K | $40.48M |
| Sixth street partners management company | 730.69K | 0.00% | 730.69K | $28.50M |
| Baker bros. advisors lp | 366.08K | 0.07% | 366.08K | $9.62M |
| Kornitzer capital management inc /ks | 155.66K | 0.13% | 155.66K | $6.07M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -1.00 |
| Cullen/frost bankers | -2.00 |
| Mather group, llc. | -3.00 |
| Eastern bank | -4.00 |
| Concord wealth partners | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 464 | 4.98% | 76,300,568 | 4.08% | 66 | 1.64% | 220 | -2.65% | 130 | 9.24% |
| Mar 31, 2026 | 295 | -36.01% | 32,143,576 | -55.31% | 28 | 0.69% | 149 | -32.58% | 76 | -45.71% |
| Dec 31, 2025 | 295 | -26.62% | 42,499,369 | -40.36% | 37 | 0.94% | 135 | -31.82% | 94 | -12.15% |
| Sep 30, 2025 | 387 | -6.52% | 69,883,492 | -2.34% | 62 | 1.53% | 194 | -15.28% | 101 | -5.61% |
| Jun 30, 2025 | 413 | 1.72% | 76,058,977 | 0.09% | 67 | 1.48% | 224 | -0.44% | 108 | 3.85% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 5.10M | 4.61% | 70.32K |
| Vanguard Total Stock Mkt Idx Inv | 3.50M | 3.02% | -23.69K |
| State Street® SPDR® S&P® Biotech ETF | 3.52M | 3.02% | 8.09K |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.51M | 3.01% | 13.84K |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.50M | 3.00% | -23.69K |
| Vanguard US Total Market Shares ETF | 3.32M | 2.96% | 2.50K |
| Vanguard Small Cap Index | 2.54M | 2.17% | 5.83K |
| SPDR® S&P Biotech ETF | 1.92M | 1.71% | 4.29K |
| Vanguard Small Cap Growth Index Inv | 1.46M | 1.26% | 39.38K |
| Vanguard MStar Small Cap Growth Indx Inv | 1.47M | 1.26% | 4.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Lian Brian | President & CEO | Sell | $4.95M |
| Jul 29, 2026 | ZANTE GREG | Chief Financial Officer | Sell | $710.14K |
| Jul 29, 2026 | Mancini Marianna | Chief Operating Officer | Sell | $609.64K |
| Mar 10, 2026 | Aubuchon Neil William | Chief Commercial Officer | Buy | $149.91K |
| Jan 05, 2026 | ZANTE GREG | Chief Financial Officer | Sell | $464.02K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 3 |
| 2026 Q2 | - | - |
| 2026 Q1 | 1 | 13 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 3 |
VKTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools